20
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Gender differences in sociodemographic and clinical characteristic and the quality of life of Chinese schizophrenia patients

, , , , , , & show all
Pages 450-455 | Received 09 Jun 2009, Accepted 12 Oct 2009, Published online: 16 Apr 2010

References

  • Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004; 161:1324–1333.
  • Usall J, Araya S, Ochoa S, Busquets E, Gost A, Marquez M. Gender differences in a sample of schizophrenic outpatients. Compr Psychiatry 2001; 42:301–305.
  • Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162:80–86.
  • Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 1996; 153:799–805.
  • Jablensky A, Cole SW. Is the earlier age at onset of schizophrenia in males a confounded finding? Results from a cross-cultural investigation. Br J Psychiatry 1997; 170:234–240.
  • Goldstein JM, Faraone SV, Chen WJ, Tolomiczencko GS, Tsuang MT. Sex differences in the familial transmission of schizophrenia. Br J Psychiatry 1990; 156:819–826.
  • Salokangas RK, Honkonen T, Saarinen S. Women have later onset than men in schizophrenia: but only in its paranoid form. Results of the DSP project. Eur Psy chiatry 2003; 18:274–281.
  • Kaplan RM. Quality of life: an outcomes perspective. Arch Phys Med Rehabil 2002; 83:S44–50.
  • Corrigan PW, Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis 1995; 183: 281–285.
  • Bechdolf A, Klosterkotter J, Hambrecht M . Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003; 253:228–235.
  • Browne S, Roe M, Lane A . Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94:118–124.
  • Meltzer HY, Burnett S, Bastani B, Ramirez LF. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990; 41:892–897.
  • Ritsner M, Ponizovsky A, Endicott J . The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002; 12:31–38.
  • Russo J, Roy-Byrne P, Reeder D . Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis 1997; 185:166–175.
  • Warner R, de Girolamo G, Belelli G, Bologna C, Fioritti A, Rosini G. The quality of life of people with schizophrenia in Boulder, Colorado, and Bologna, Italy. Schizophr Bull 1998; 24:559–568.
  • Weng YZ, Xu MJ, Li DL, Guo FY, Huang Q, Fu T. Assessment of expressed emotion in family members of schizophrenic patients in Beijing. Modern Rehabil 2001; 5:39–42.
  • Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS. Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors. Qual Life Res 2008; 17:27–36.
  • Lobana A, Mattoo SK, Basu D, Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatr Scand 2001; 104:51–55.
  • Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984; 39:187–193.
  • Shin SK, Lukens EP. Effects of psychoeducation for Korean Americans with chronic mental illness. Psychiatr Serv 2002; 53:1125–1131.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62.
  • Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11–19.
  • Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672–676.
  • Rudnick A. The impact of coping on the relation between symptoms and quality of life in schizophrenia. Psychiatry 2001; 64:304–308.
  • WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28:551–558.
  • Fang JQ, Hao YT, Li CX. Reliability and validity for Chinese version of WHO quality of life scale. Chin Ment Health J 1999; 13:203–205 (in Chinese).
  • Sim K, Su A, Leong JY . High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry 2004; 37:175–179.
  • Grunebaum MF, Oquendo MA, Harkavy-Friedman JM . Delusions and suicidality. Am J Psychiatry 2001; 158:742–747.
  • Angermeyer MC, Kuhn L. Gender differences in age at onset of schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci 1988; 237:351–364.
  • Faraone SV, Chen WJ, Goldstein JM, Tsuang MT. Gender differences in age at onset of schizophrenia. Br J Psychiatry 1994; 164:625–629.
  • Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984; 41:157–161.
  • DeLisi LE. The significance of age of onset for schizophrenia. Schizophr Bull 1992; 18:209–215.
  • Hafner H, Behrens S, De Vry J, Gattaz WF. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci 1991; 241:65–68.
  • Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994; 51:477–484.
  • Goldstein JM, Santangelo SL, Simpson JC, Tsuang MT. The role of gender in identifying subtypes of schizophrenia: a latent class analytic approach. Schizophr Bull 1990; 16:263–275.
  • Castle DJ. Epidemiology of women and schizophrenia. Castle DJ, McGrath J, Kulkarni J. Women and schizophreia. Cambridge: Cambridge University Press; 2000:19–33.
  • Drake RE, Gates C, Whitaker A, Cotton PG. Suicide among schizophrenics: a review. Compr Psychiatry 1985; 26:90–100.
  • Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS. Socio-demographic and clinical correlates of lifetime suicide attempts and their impact on quality of life in Chinese schizophrenia patients. J Psychiatr Res 2008; 42:495–502.
  • Ma X, Xiang YT, Cai ZJ . Lifetime prevalence of suicidal ideation, suicide plans and attempts in rural and urban regions of Beijing, China. Aust N Z J Psychiatry 2009; 43:158–166.
  • Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163:183–189.
  • Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003; 28 (Suppl 2):17–54.
  • Xu WW, Wu SZ, Zheng FJ . An investigation of present situation in patients with schizophrenia over 5-year courses in Wuxi City. J Clin Psychol Med 2007; 17:19–21 (in Chinese).
  • Lei ZB. Sex differences in medication-induced side effects. Adverse Drug Reactions J 2000; 3:177–179 (in Chinese).
  • Melkersson KI, Hulting AL, Rane AJ. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. Br J Clin Pharmacol 2001; 51:317–324.
  • Pollock BG. Gender differences in psychotropic drug metabolism. Psychopharmacol Bull 1997; 33:235–241.
  • Pinals DA, Malhotra AK, Missar CD, Pickar D, Breier A. Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophr Res 1996; 22:215–222.
  • Angermeyer MC, Kuhn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990; 16:293–307.
  • Brunette MF, Drake RE. Gender differences in patients with schizophrenia and substance abuse. Compr Psychiatry 1997; 38:109–116.
  • Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 1997; 6:21–26.
  • Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual Life Res 1993; 2:239–251.
  • Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health program clients: validating a measure. Community Ment Health J 1991; 27:43–55.
  • Lehman AF, Ward NC, Linn LS. Chronic mental patients: the quality of life issue. Am J Psychiatry 1982; 139:1271–1276.
  • Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984; 10:300–312.
  • Ritsner M, Modai I, Endicott J . Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61:880–889; quiz 890.
  • Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99:119–124.
  • Pitkanen A, Hatonen H, Kuosmanen L, Valimaki M. Patients’ descriptions of nursing interventions supporting quality of life in acute psychiatric wards: a qualitative study. Int J Nurs Stud 2008; 45:1598–1606.
  • Hansson L, Middelboe T, Sorgaard KW . Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings. Acta Psychiatr Scand 2002; 106:343–350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.